VIENNA — Anti-Ro/SSA antibodies may help predict which patients with systemic sclerosis (SSc) are at a greater risk for interstitial lung disease (ILD) and may serve as a biomarker to guide screening, according to an analysis of data from a large European cohort. The researchers were led by Blaž Burja…
Read More
Anti-Ro/SSA Antibodies Have Potential to Predict ILD in SSc
![Anti-Ro/SSA Antibodies Have Potential to Predict ILD in SSc](https://www.unifitrip.com/wp-content/uploads/2024/06/72514-anti-ro-ssa-antibodies-have-potential-to-predict-ild-in-ssc.jpg)
Recent Comments